Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announces that through its wholly-owned U.S. subsidiary Medicure Pharma Inc., it has closed on the acquisition of 100% of Gateway Medical Pharmacy Inc. (“Gateway”) from an arms-length third-party (the “Transaction”). As previously disclosed, the acquisition of Gateway aligns with Medicure’s strategic plan for the expansion of the Company’s direct-to-consumer pharmacy business, and positions Medicure to accelerate its growth of ZYPITAMAG® and its other products and services.
Read the full article: Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medicure-announces-closing-of-purchase-agreement-for-the-acquisition-o-998834